Insertable Cardiac News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Insertable Cardiac. Real-time updates on events, politics, business and more.

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

December 28, 2023

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the...

United States Oussama Wazni Lauren Tengler Steve Bailey Brad Sutton Drug Administration

Source: prnewswire.com

Medtronic receives FDA clearance for expanded indication of LINQ II™ insertable cardiac monitor for use in pediatric patients ages 2 and older

September 20, 2022

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient populationDUBLIN, Sept. 20, 2022 /PRNe...

Julie Brewer Ryan Weispfenning Joey Lomicky Jennifer Silva Exchange Commission Drug Administration

Source: businessinsider.com

Medtronic Receives FDA Clearance for Expanded Indication of LINQ II Insertable Cardiac Monitor For Use in Pediatric Patients Ages 2 and Older

September 20, 2022

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population

Julie Brewer Jennifer Silva Drug Administration Heart Rhythm Society Conference Washington University In St Cardiac Monitor

Source: dicardiology.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Insertable Cardiac News Today

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE&#x2122; Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

Medtronic receives FDA clearance for expanded indication of LINQ II&#x2122; insertable cardiac monitor for use in pediatric patients ages 2 and older

Medtronic Receives FDA Clearance for Expanded Indication of LINQ II Insertable Cardiac Monitor For Use in Pediatric Patients Ages 2 and Older

Explore More Categories

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

Medtronic receives FDA clearance for expanded indication of LINQ II™ insertable cardiac monitor for use in pediatric patients ages 2 and older